Articles tagged "Waiting lists"

2019 American Transplant Congress
Impact of Enteric Vancomycin Resistant Enterococcus Colonization on Waitlist Outcomes among Liver Transplant Candidates
E. Aldag, R. Pedersen, V. Gunabushanam, A. Sahajpal, T. J. Dilworth
Aurora St Luke's Medical Center, Milwaukee, WI
*Purpose: To determine the impact of Vancomycin Resistant Enterococcus (VRE) colonization on 90-day Liver Transplant (LT) waitlist outcomes.*Methods: Single center, retrospective observational study of LT…
2019 American Transplant Congress
Willingness to Acquire Donor-Derived Hepatitis C Infection May Reduce Waitlist Mortality for Heart Transplant Candidates
B. E. Lonze, A. Reyentovich, N. Moazami, D. E. Smith, C. Gidea, R. A. Montgomery
NYU Langone Transplant Institute, New York, NY
*Purpose: Hearts from deceased donors with hepatitis C infection (HCV+) are disproportionately discarded because most waitlist registrants are HCV negative (HCV-). For some with end-organ…
2019 American Transplant Congress
Center Variability in Organ Offer Acceptance and Waitlist Mortality in Lung Transplantation
A. Y. Choi¹, M. S. Mulvihill², J. Weber³, H. Lee³, M. Cox², B. Yerokun², M. Kuchibhatla³, J. A. Klapper², M. G. Hartwig²
¹Duke University School of Medicine, Durham, NC, ²Department of Surgery, Duke University Medical Center, Durham, NC, ³Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC
*Purpose: Lung transplantation (LTx) offers a survival benefit for patients with end-stage lung disease. When suitable donors are identified, centers must accept or decline the…
2019 American Transplant Congress
Center-Level Probability of Kidney Transplant Varies Considerably for Waitlisted Patients
K. L. King¹, S. A. Husain¹, P. Reese², J. Schold³, S. Pastan⁴, S. Mohan¹
¹Columbia University, New York, NY, ²University of Pennsylvania, Philadelphia, PA, ³Cleveland Clinic, Cleveland, OH, ⁴Emory University, Atlanta, GA
*Purpose: Prior studies identify reducing time spent on the waitlist as a top priority for deceased donor kidney (DDK) transplant (Tx) candidates. Despite well-described geographic…
2019 American Transplant Congress
Vaccination And Allosensitization In Solid Organ Transplant Candidates
L. Lourenco¹, K. B. Bain², L. Bowman³, D. C. Brennan⁴, G. A. Ewald⁵, R. R. Hachem⁶
¹Pharmacy, University of Chicago Medicine, Chicago, IL, ²Pharmacy, Barnes-Jewish Hospital, St. Louis, MO, ³Pharmacy, Tampa General Hospital, Tampa, FL, ⁴Internal Medicine, The Johns Hopkins School of Medicine, Baltimore, MD, ⁵Heart Failure and Heart Transplantation, Washington University School of Medicine, St. Louis, MO, ⁶Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, MO
*Purpose: Clinical practice guidelines recommend vaccinating patients awaiting solid organ transplantation (SOT) against vaccine-preventable infections, but there is little evidence to suggest that vaccination reduces…
2019 American Transplant Congress
Development and Implementation of a Pediatric Transplant Consortium
K. Soltys¹, S. K. Rassmussen², J. Squires³, R. Sindhi¹, S. Pelletier², K. Brayman², M. Angelis⁴, T. Chin⁴, R. Teaster², J. Oberholzer², R. Gonzalez-Peralta⁵, B. Friedman⁴, D. Hupp⁶, M. Mendoza⁷, P. A. Eicker⁶, J. Middleton⁷, G. Mazariegos¹
¹Transplant Surgery, Childrens Hospital of Pittsburgh of UPMC, Pittsburgh, PA, ²Charles O. Strickler Transplant Center, University of Virginia, Charlottesville, VA, ³Hepatology, Childrens Hospital of Pittsburgh of UPMC, Pittsburgh, PA, ⁴AdventHealth Transplant Institute, Florida Hospital, Orlando, FL, ⁵AdventHealth for Children, Florida Hospital, Orlando, FL, ⁶Nursing, Childrens Hospital of Pittsburgh of UPMC, Pittsburgh, PA, ⁷Hepatology, University of Virginia, Charlottesville, VA
*Purpose: Access to pediatric liver transplant expertise varies nationally and variability in practice leads to potential suboptimal organ utilization and outcomes. A multi-institutional collaborative was…
2019 American Transplant Congress
Impact of the Pediatric End-Stage Liver Disease Growth Failure Threshold on Waitlist Mortality in Children Awaiting Liver Transplant
S. M. Swenson, J. P. Roberts, S. Rhee, E. R. Perito
University of California, San Francisco, San Francisco, CA
*Purpose: To examine the impact on waitlist mortality of Pediatric End-Stage Liver Disease (PELD)’s incorporation of growth failure (GF) as a threshold variable—present or absent…
2019 American Transplant Congress
Assessment of Physical Frailty is Positively Correlated with LAS Score in Lung Transplant Candidates
S. Jaladanki¹, L. Shih¹, O. Kwon², N. Ventigan², D. Nanayakkara², S. Weigt³, J. Singer⁴, A. Ardehali¹, R. Biniwale¹, D. Goldwater⁵, J. Schaenman²
¹Department of Cardiac Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, ²Division of Infectious Diseases, David Geffen School of Medicine at UCLA, Los Angeles, CA, ³Division of Pulmonary and Critical Care, David Geffen School of Medicine at UCLA, Los Angeles, CA, ⁴Division of Pulmonary and Critical Care, UCSF School of Medicine, San Francisco, CA, ⁵Division of Geriatrics, David Geffen School of Medicine at UCLA, Los Angeles, CA
*Purpose: We proposed to evaluate physical frailty in lung transplant candidates to determine whether physical frailty correlated with LAS score and added to ability to…
2019 American Transplant Congress
The Benefit of Kidney Transplantation over the Waitlist Depends on the Patient’s Comorbidities
A. Andrade Izquierdo¹, J. V. Reusing Jr¹, V. Onusic¹, F. Agena¹, F. C. Lemos¹, F. de Paula¹, F. Gerab², E. David-Neto¹
¹Renal Transplantation Service, Hospital das Clínicas - University of São Paulo School of Medicine, Sao Paulo, Brazil, ²Department of Mathematics, FEI University, Sao Paulo, Brazil
*Purpose: This study aimed to determine the impact of different comorbidities to the survival benefit of Kidney Transplantation (KTx) compared to waitlisted (WL) patients in…
2019 American Transplant Congress
A Prognostic Drug Development Tool to Assess the Transplantability at the Time of Listing for Kidney Transplant Candidates
S. Kawakita¹, L. Hidalgo-Semlek², J. L. Beaumont¹, J. Lee², M. J. Everly¹
¹Terasaki Research Institute, Los Angeles, CA, ²Hansa Medical AB, Lund, Sweden
*Purpose: At time of listing for kidney transplant (KT), a patient is not informed of the probabilities of KT, death, or remaining on the waiting…